Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:FDX
NYSE:FDXLogistics

FedEx (FDX) Q2 2026 Margin Stability Keeps Efficiency Narratives Under Scrutiny

FedEx (FDX) has posted Q2 2026 results with revenue of $23.5 billion and basic EPS of $4.07, anchored by net income of $956 million as the company continues to navigate a steady but measured freight environment. The company has seen revenue move from $21.6 billion in Q3 2025 to $22.0 billion in Q4 2025, $22.2 billion in Q1 2026, and now $23.5 billion in Q2 2026. Basic EPS has ranged from $3.78 to $6.92 over that stretch before landing at $4.07 this quarter, setting up a picture of consistent...
NYSE:FINV
NYSE:FINVConsumer Finance

Is FinVolution’s New AI Risk Framework Reshaping The Investment Case For FinVolution Group (FINV)?

Earlier this month, FinVolution Group hosted a closed-door technology forum titled "New AI Paradigms: The Core Logic Driving Future Development," where it gathered over 20 leading AI scholars and unveiled an AI framework that blends commercial and proprietary models to strengthen risk management and customer service. The company also flagged an upcoming white paper on embedding multimodal large models into cross-border fintech operations, highlighting how AI could reshape its international...
NYSE:ACN
NYSE:ACNIT

Accenture (ACN) Q1 2026 Margin Slippage Reinforces Concerns Over Slowing Profit Growth

Accenture (ACN) opened fiscal 2026 with Q1 revenue of about $18.7 billion and basic EPS of $3.57, setting the tone for another year where profit growth is firmly in focus. The company has seen quarterly revenue move from roughly $16.4 billion in Q4 2024 to $18.7 billion in Q1 2026, while basic EPS has ranged between about $2.27 and $3.64 over that stretch. This gives investors a clear view of how top line and per share earnings have been tracking. With trailing net margins easing a touch and...
CNSX:CL
CNSX:CLPharmaceuticals

Cresco Labs (CNSX:CL) Is Up 55.2% After Cannabis Rescheduling News Is The Bull Case Changed?

Cresco Labs recently welcomed the U.S. federal government’s move to reschedule cannabis from Schedule I to Schedule III, calling it a historic policy shift for the regulated cannabis industry. The company highlighted that rescheduling could ease tax burdens, improve access to banking and research, and further legitimize state-regulated cannabis markets, directly supporting its brand-building and expansion efforts. We’ll now examine how easing federal tax burdens and banking frictions could...
NasdaqGS:SATS
NasdaqGS:SATSMedia

Is EchoStar’s 350.9% Surge in 2025 Still Justified After Recent Integration Moves?

If you are wondering whether EchoStar’s explosive run still has room to continue, or if the market has already priced in the story, you are not alone. This is exactly where a closer look at valuation comes in. After a massive 350.9% year to date gain and 353.7% rise over the last year, the stock has recently cooled off a bit, with a 1.7% pullback over the past week. This could signal either a healthy breather or early profit taking. Recent headlines have focused on EchoStar’s strategic...
NasdaqCM:MDXG
NasdaqCM:MDXGBiotechs

How New Immunomodulation Data on Placental Allografts Will Impact MiMedx Group (MDXG) Investors

MiMedx Group recently published new peer-reviewed data in the Journal of Inflammation showing that its Purion-processed DHACM and LHACM placental allografts exert multifactorial immunomodulatory effects on key inflammatory cells involved in wound healing. The findings that these allografts both temper inflammatory monocyte and macrophage activity and enhance pro-reparative functions such as efferocytosis and cell survival could strengthen the medical community’s confidence in MiMedx’s...
NasdaqGS:SHC
NasdaqGS:SHCLife Sciences

3 Stocks Estimated To Be Undervalued By Up To 48.3%

As the U.S. stock market experiences a resurgence, with major indices like the Nasdaq and S&P 500 seeing notable gains driven by tech shares, investors are keenly observing opportunities that may arise from these fluctuations. In such an environment, identifying undervalued stocks can be crucial for those looking to capitalize on potential growth while maintaining a balanced portfolio amidst shifting market dynamics.
NasdaqGS:ATEC
NasdaqGS:ATECMedical Equipment

3 Growth Companies With High Insider Ownership Seeing Earnings Growth Up To 68%

As the U.S. stock market experiences a surge, particularly in tech shares, investors are closely monitoring growth companies with high insider ownership as potential opportunities amidst this renewed risk appetite. In such an environment, stocks that combine robust earnings growth with significant insider stakes can offer insights into management confidence and alignment with shareholder interests.